Finance

Lists
6849:TYO
Nihon Kohden Corp
Â¥1,515.00
+5.61%
(+80.50) 1D
Aug 10, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 6849...
Open
Â¥1,480
High
Â¥1,518
Low
Â¥1,450
Mkt. cap
254.46B
Avg. vol.
707.70K
Volume
1.17M
Dividend
2.11%
Quarterly dividend
Â¥8
Ex-dividend date
Sep 29, 2026
P/E ratio
18.04
52-wk high
Â¥1,886
52-wk low
Â¥1,323
EPS
Â¥84
Shares outstanding
86.16M
No. of employees
6K
Open
Â¥1,480
High
Â¥1,518
Low
Â¥1,450
Mkt. cap
254.46B
Avg. vol.
707.70K
Volume
1.17M
Dividend
2.11%
Quarterly dividend
Â¥8
Ex-dividend date
Sep 29, 2026
P/E ratio
18.04
52-wk high
Â¥1,886
52-wk low
Â¥1,323
EPS
Â¥84
Shares outstanding
86.16M
No. of employees
6K
News stories
From web sources and news partners
Profile
Nihon Kohden Corporation is a Tokyo-based leading manufacturer, developer and distributor of medical electronic equipment, which include EEGs, EMG measuring systems, ECGs, patient monitors, Invasive and Non-Invasive Ventilators, Defibrillators, AEDs and clinical information systems, with subsidiaries in the U.S., Europe and Asia. The company's products are now used in more than 120 countries, and it is the largest supplier of EEG products worldwide. In 1972, Takuo Aoyagi, a researcher at the company, invented and patented the basic principles of pulse oximetry. Two years later he developed the world's first pulse oximeter, the OLV-5100, which has helped improve patient safety during anaesthesia. Wikipedia
About Nihon Kohden Corp
CEO-
Employees6.12K
FoundedAug 7, 1951
HeadquartersShinjuku City, Tokyo, Japan
SectorMedical device
Website-
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
58.10B
55.89B
71.09B
47.40B
Cost of goods sold
27.62B
27.60B
34.45B
21.95B
Cost of revenue
27.62B
27.60B
34.45B
21.95B
Research and development expenses
-
-
7.45B
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.14B
25.90B
15.84B
26.44B
Operating expense
25.14B
25.88B
27.03B
26.44B
Total operating expenses
52.76B
53.48B
61.47B
48.38B
Operating income
5.34B
2.41B
9.61B
-976.00M
Other non operating income
17.00M
85.00M
61.00M
57.00M
EBT including unusual items
6.26B
3.15B
10.05B
-311.00M
EBT excluding unusual items
6.27B
5.15B
10.69B
-339.00M
Income tax expense
1.87B
1.26B
1.95B
445.00M
Effective tax rate
29.92%
40.17%
19.36%
-143.09%
Other operating expenses
-
-
-
-
Net income
4.39B
1.88B
8.10B
-756.00M
Net profit margin
7.55%
3.37%
11.40%
-1.59%
Earnings per share
-
-
-
-
Interest and investment income
91.00M
116.00M
113.00M
95.00M
Interest expense
-39.00M
-83.00M
-112.00M
-114.00M
Net interest expenses
52.00M
33.00M
1.00M
-19.00M
Depreciation and amortization charges
-
-
3.73B
-
EBITDA
6.98B
3.90B
11.25B
610.00M
Gain or loss from assets sale
-
-
58.00M
-28.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps